Price Alert

Alpine Immune Sciences In... (ALPN)

NASDAQ: ALPN · Real-Time Price · USD

64.97

0.01 (0.02%)

At close: May 17, 2024, 10:00 PM

Alpine Immune Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	33.02M	43.92M	18.98M	34.08M	14.46M	13.38M	126.63M	24.36M	34.89M	67.91M	76.1M	18.81M	12.63M
Short-Term Investments	272.65M	283.49M	174.47M	169.72M	180.46M	224.26M	122.24M	143.5M	136.98M	94.4M	104.53M	72.25M	84.19M
Long-Term Investments	56.45M	40.82M	33.5M	35.56M	53.17M	35.48M	28.02M	33.04M	46.95M	52.87M	39.06M	9.12M	18.32M
Other Long-Term Assets	269K	268K	254K	254K	254K	254K	254K	254K	254K	11.02M	254K	254K	254K
Receivables	543K	749K	878K	688K	713K	709K	677K	1.64M	453K	25.32M	554K	45.34M	317K
Inventory	n/a	n/a	n/a	-404K	-45K	-317K	n/a	n/a	n/a	-323K	n/a	n/a	n/a
Other Current Assets	2.05M	1.87M	3.08M	3.24M	3.19M	2.96M	3.7M	2.79M	3.77M	4.71M	2.57M	3.33M	3.35M
Total Current Assets	308.25M	330.03M	197.41M	207.32M	198.78M	240.99M	253.24M	172.29M	176.1M	192.01M	183.75M	139.74M	100.48M
Property-Plant & Equipment	8.67M	8.99M	9.23M	9.55M	9.74M	9.8M	9.99M	10.13M	10.42M	10.55M	10.35M	10.64M	10.93M
Goodwill & Intangibles	n/a	-268K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-10.77M	n/a	n/a	n/a
Total Long-Term Assets	65.39M	51.78M	43.13M	45.52M	63.32M	45.69M	38.36M	43.54M	57.84M	63.89M	49.73M	20.08M	29.5M
Total Assets	373.65M	381.81M	240.55M	252.84M	262.1M	286.69M	291.6M	215.83M	233.94M	255.9M	233.48M	159.82M	129.98M
Account Payables	4.17M	3.59M	3.07M	1.65M	1.66M	4.29M	3.24M	1.81M	1.9M	3.35M	1.84M	1.39M	466K
Deferred Revenue	10.23M	16.29M	30.09M	37.25M	40.4M	35.57M	46.21M	42.92M	51.76M	51.77M	48.1M	48.96M	34.52M
Short-Term Debt	950K	912K	870K	829K	3M	4.14M	5.26M	5.36M	5.3M	5.24M	5.34M	5.28M	4.43M
Other Current Liabilities	16.89M	21.19M	17.79M	13.68M	12.03M	14M	13.74M	12.53M	9.2M	9.42M	8.65M	4.61M	3.95M
Total Current Liabilities	32.24M	41.98M	51.82M	53.41M	57.09M	58M	68.46M	62.62M	68.17M	69.78M	63.93M	60.25M	43.37M
Long-Term Debt	8.71M	9M	9.29M	9.56M	9.83M	10.09M	10.33M	11.59M	13M	14.39M	15.76M	17.12M	18.07M
Other Long-Term Liabilities	n/a	-1.96M	17.81M	20.48M	25.64M	39.19M	30.8M	-1.02M	37.35M	50.83M	30.96M	38.62M	15.25M
Total Long-Term Liabilities	8.71M	11.89M	27.1M	30.04M	35.47M	49.27M	41.13M	53.67M	50.35M	65.22M	46.72M	55.74M	33.32M
Total Liabilities	40.94M	53.87M	78.92M	83.45M	92.56M	107.27M	109.59M	116.29M	118.51M	135M	110.66M	115.99M	76.68M
Total Debt	9.65M	9.91M	10.16M	10.39M	12.83M	14.22M	15.59M	16.95M	18.3M	19.63M	21.1M	22.4M	22.49M
Common Stock	66K	60K	49K	49K	48K	46K	44K	30K	30K	30K	29K	24K	24K
Retained Earnings	-274.06M	-256.14M	-262.11M	-250.38M	-237.23M	-223.96M	-205.1M	-191.82M	-173.73M	-166.2M	-151.03M	-137.54M	-126.51M
Comprehensive Income	-263K	397K	-540K	-650K	-407K	-1.12M	-1.67M	-1.37M	-1.06M	-273K	15K	45K	33K
Shareholders Equity	332.7M	327.94M	161.63M	169.39M	169.54M	179.42M	182.01M	99.54M	115.43M	120.9M	122.83M	43.83M	53.29M
Total Investments	329.1M	324.31M	207.97M	205.28M	233.63M	259.75M	150.25M	176.54M	183.93M	147.26M	143.59M	81.37M	102.5M